<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The ubiquitin C-terminal hydrolase-L1 (UCH-L1) is a deubiquitinating enzyme that catalyses the hydrolysis of polyubiquitin precursors and small ubiquitin adducts </plain></SENT>
<SENT sid="1" pm="."><plain>UCH-L1 has been detected in a variety of malignant and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic tumours</z:e> but its biological function in these cells is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We have previously shown that UCH-L1 is highly expressed in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and is up-regulated upon <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of B lymphocytes with Epstein-Barr virus (EBV) </plain></SENT>
<SENT sid="3" pm="."><plain>Here we show that knockdown of UCH-L1 by RNAi inhibits the proliferation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells in suspension and semisolid agar and activates strong LFA-1-dependent homotypic <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Induction of cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> correlated with <z:chebi fb="36" ids="36916">cation</z:chebi>-induced binding to ICAM-1, clustering of LFA-1 into <z:chebi fb="23" ids="18059">lipid</z:chebi> rafts and constitutive activation of the Rap1 and Rac1 GTPases </plain></SENT>
<SENT sid="5" pm="."><plain>Expression of a catalytically active UCH-L1 promoted the proliferation of a UCH-L1-negative EBV transformed lymphoblastoid cell line (LCL) and inhibited cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, whereas a catalytic mutant had no effect, confirming the requirement of UCH-L1 enzymatic activity for the regulation of these phenotypes </plain></SENT>
<SENT sid="6" pm="."><plain>Our results identify UCH-L1 as a new player in the signalling pathways that promote the proliferation and invasive capacity of malignant B cells </plain></SENT>
</text></document>